Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1948 1
1953 1
1958 1
1970 1
1977 1
1978 1
1993 1
1994 1
1999 1
2020 1
2022 1
2023 2
2024 1
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial.
Tofte N, Lindhardt M, Adamova K, Bakker SJL, Beige J, Beulens JWJ, Birkenfeld AL, Currie G, Delles C, Dimos I, Francová L, Frimodt-Møller M, Girman P, Göke R, Havrdova T, Heerspink HJL, Kooy A, Laverman GD, Mischak H, Navis G, Nijpels G, Noutsou M, Ortiz A, Parvanova A, Persson F, Petrie JR, Ruggenenti PL, Rutters F, Rychlík I, Siwy J, Spasovski G, Speeckaert M, Trillini M, Zürbig P, von der Leyen H, Rossing P; PRIORITY investigators. Tofte N, et al. Lancet Diabetes Endocrinol. 2020 Apr;8(4):301-312. doi: 10.1016/S2213-8587(20)30026-7. Epub 2020 Mar 2. Lancet Diabetes Endocrinol. 2020. PMID: 32135136 Free article. Clinical Trial.
Effect of spironolactone wash-out on albuminuria after long-term treatment in individuals with type 2 diabetes and high risk of kidney disease-An observational follow-up of the PRIORITY study.
Wasehuus V, Rotbain Curovic V, Tofte N, Lindhardt M, Currie G, Delles C, Frimodt-Møller M, Mischak H, von der Leyen H, Hansen TW, Kümler T, Persson F, Rossing P; PRIORITY Study group. Wasehuus V, et al. Diabetes Obes Metab. 2025 Jan;27(1):387-393. doi: 10.1111/dom.16037. Epub 2024 Oct 28. Diabetes Obes Metab. 2025. PMID: 39468380 Clinical Trial.
[Infant nutrition].
RIIS D. RIIS D. Tidsskr Nor Laegeforen. 1953 Dec 1;73(23):888-92. Tidsskr Nor Laegeforen. 1953. PMID: 13146635 Undetermined Language. No abstract available.
Multi-region investigation of 'man' as default in attitudes.
Phills CE, Miller JK, Buchanan EM, Williams A, Meyers C, Brown ER, Zickfeld J, Volsa S, Stieger S, Oberzaucher E, Mlakic V, Vasilev M, Dalgar İ, Çoksan S, Söylemez S, Solak Ç, Özdoğru AA, Çoktok B, Kung CC, Suavansri P, Manley H, Álvarez-Solas S, Ricaurte DZ, Ropovik I, Baník G, Babinčák P, Adamkovič M, Kačmár P, Hricová M, Bavoľár J, Li L, Gao F, Chen Z, Ković V, Gvozdenović V, Arriaga P, Filip K, Barzykowski K, Adamus S, Pfuhl G, Martiny SE, Klevjer K, Woelfert FS, Tamnes CK, Kunst JR, Korbmacher M, Singh MM, Pradhan S, Parveen N, Parganiha A, Pande B, Kujur P, Chandel P, Reggev N, Mokady A, Papadatou-Pastou M, Schnepper R, Röer JP, Ripp T, Pronizius E, Lamm C, Voracek M, Olsen J, Enachescu J, Batres C, Storage D, Levitan CA, Li M, Vaughn LA, Chopik WJ, Schmidt K, Mallik PR, Lewis S, Leach B, Jurosic B, Moreau D, Ndukaihe ILG, Arinze NC, Janssen SMJ, Foo A, Tan CBY, Williams GP, Riis D, Lane BM, Lynott D, Evans TR, Sirota M, Holford DL, Werner KM, Wang K, Milyavskaya M, Stephen ID, Ross RM, Roberts A, Ghasemi O, Steffens NK, Peters K, Dixson B, Varella MAC, Valentova JV, Mafra AL, Hsu RMCS, de Moraes YL, da Silva LO, da Silva CSA, Helmy M, Balderrama M, Al-Hoorie AH, McGe… See abstract for full author list ➔ Phills CE, et al. Among authors: riis d. PLoS One. 2025 Jun 25;20(6):e0323938. doi: 10.1371/journal.pone.0323938. eCollection 2025. PLoS One. 2025. PMID: 40560856 Free PMC article.
17 results